Conjugated polymeric particle and method of making same

Patent metadata

Field	Value
Publication number	US-9938577-B2
Application number	US-201514855705-A
Country	US
Kind code	B2
Filing date	Sep 16, 2015
Priority date	Feb 9, 2012
Publication date	Apr 10, 2018
Grant date	Apr 10, 2018

Abstract

A method of conjugating a substrate includes exchanging a counter ion associated with a biomolecule with a lipophilic counter ion to form a biomolecule complex, dispersing the biomolecule complex in a nonaqueous solvent, and coupling the biomolecule complex to a substrate in the presence of the nonaqueous solvent.

First claim

What is claimed is:

1. A method of conjugating a substrate, the method comprising:
exchanging a cationic counter ion ionically bound to a biomolecule for a cationic lipophilic counter ion to form a lipophilic biomolecule complex, wherein the cationic lipophilic counter ion is an ion that when complexed with the biomolecule increases the lipophilicity of the biomolecule complex, the biomolecule including a reactive group;
dispersing the lipophilic biomolecule complex in a nonaqueous solvent, wherein the nonaqueous solvent is non-reactive with a coupling group on the substrate and the reactive groups on the biomolecule; and
coupling the lipophilic biomolecule complex to a substrate in the presence of the nonaqueous solvent, the substrate including the coupling group reactive with the reactive group of the biomolecule, thereby conjugating the biomolecule to the substrate, wherein the coupling group includes one of a nucleophile or an electrophile and the reactive group includes the other of the nucleophile or the electrophile.

2. The method of claim 1 , wherein the biomolecule is a polynucleotide.

3. The method of claim 1 , wherein the cationic lipophilic counter ion is a lipophilic ammonium ion, a lipophilic phosphonium ion, a lipophilic arsonium ion, a lipophilic sulfonium ion, or a combination thereof.

4. The method of claim 3 , wherein the lipophilic ammonium ion is a tetraalkylammonium, a tetraarylammonium, mixed alkyl and aryl ammonium, or a combination thereof.

5. The method of claim 4 , wherein the lipophilic ammonium ion is selected from the group consisting of tetramethylammonium, tetraethylammonium, tetrapropylammonium, tetrabutylammonium, tetrapentylammonium, tetrahexylammonium, tetraheptylammonium, tetraoctylammonium, alkyl and aryl mixtures thereof, and a combination thereof.

6. The method of claim 3 , wherein the lipophilic phosphonium ion is tetraphenylphosphonium.

7. The method of claim 3 , wherein the lipophilic arsonium ion is a tetraalkylarsonium, a tetraarylarsonium, a mixed alkyl and aryl arsonium ion, or a combination thereof.

8. The method of claim 7 , wherein the lipophilic arsonium ion is tetraphenylarsonium.

9. The method of claim 3 , wherein the lipophilic sulfonium ion is a trialkylsulfonium ion.

10. The method of claim 1 , wherein the nonaqueous solvent is polar.

11. The method of claim 1 , wherein the nonaqueous solvent comprises an amide, a urea, a carbonate, an ether, a sulfoxide, a sulfone, a hindered alcohol, or a combination thereof.

12. The method of claim 11 , wherein the amide or urea is selected from a group consisting of formamide, N,N-dimethylformamide, acetamide, N,N-dimethylacetamide, hexamethylphosphoramide, pyrrolidone, N-methylpyrrolidone, N,N,N′,N′-tetramethylurea, N,N′-dimethyl-N,N′-trimethyleneurea, and a combination thereof.

13. The method of claim 11 , wherein the carbonate is selected from a group consisting of dimethyl carbonate, propylene carbonate, and a combination thereof.

14. The method of claim 11 , wherein the ether is tetrahydrofuran.

15. The method of claim 11 , wherein the sulfoxide or sulfone is selected from a group consisting of dimethylsulfoxide, dimethylsulfone, and a combination thereof.

16. The method of claim 1 , wherein the substrate comprises a polymeric particle.

17. A method of conjugating a polymeric particle, the method comprising:
exchanging a cationic counter ion ionically bound to a polynucleotide for a lipophilic cationic counter ion to form a polynucleotide complex, the polynucleotide including a nucleophilic or an electrophilic terminal reactive group, wherein the cationic lipophilic counter ion is an ion that when complexed with the polynucleotide increases the lipophilicity of the polynucleotide complex;
dispersing the polynucleotide complex in a non-reactive, nonaqueous solvent; and
coupling the polynucleotide complex to the polymeric particle by nucleophilic or electrophilic substitution, the polymeric particle including a coupling group, the coupling group including an electrophilic group or a nucleophilic group opposite to the nucleophilic or electrophilic terminal reactive group of the polynucleotide, wherein the coupling group includes one of a nucleophile or an electrophile and the reactive group includes the other of the nucleophile or the electrophile.

18. The method of claim 17 , wherein the lipophilic cationic counter ion is a lipophilic ammonium ion, a lipophilic phosphonium ion, a lipophilic arsonium ion, a lipophilic sulfonium ion, or a combination thereof.

19. The method of claim 17 , wherein the non-reactive nonaqueous solvent comprises an amide, a urea, a carbonate, an ether, a sulfoxide, a sulfone, a hindered alcohol, or a combination thereof.

Assignees

• Life Technologies Corp

Inventors

• Menchen Steven M
• Blanchard Alan
• Andruzzi Luisa
• Khan Shaheer H
• Gremyachinskiy Dmitriy
• Lui Alfred
• Stolarczyk Craig
• Sokolsky Tanya
• Thwar Prasanna Krishnan

Classifications

• C08F8/40

  Introducing phosphorus atoms or phosphorus-containing groups · CPC title

• C12Q1/6876 Primary

  Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

• C12Q1/6813 Primary

  Hybridisation assays · CPC title

• C12Q1/6834 Primary

  Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title

• C12Q2523/101

  Crosslinking agents, e.g. psoralen · CPC title